Trial Profile
A RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, PARALLEL-GROUP TRIAL TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF P-3073 FOR TOPICAL TREATMENT OF NAIL PSORIASIS
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Calcipotriol (Primary)
- Indications Psoriasis
- Focus Registrational; Therapeutic Use
- Sponsors Polichem
- 11 Apr 2017 Status changed from active, no longer recruiting to completed.
- 28 Mar 2017 This trial has been completed in Bulgaria (End date:2017-02-08) as per European Clinical Trials Database record.
- 23 Mar 2017 This trial has been completed in Germany (end date: 8 Feb 2017 ).